Intel Corporation [INTC]
No date in this file is invented. Unannounced dates are marked ESTIMATE with the prior-year basis stated.
Fiscal year ends the last Saturday of December. Reporting cadence: Q1 late April, Q2 late July, Q3 late October, Q4/FY late January.
| Date | Status | Event | What it tests |
|---|---|---|---|
| 23 Jul 2026 (passed) | actual | Q2 2026 results | Delivered: revenue $16,128m +25.4%, GAAP operating margin +11.1%, GAAP EPS −$2.16, non-GAAP +$0.42, external foundry revenue $293m |
| ~22–29 Oct 2026 | ESTIMATE (2025-10-23, 2024-10-31, 2023-10-26 actuals) | Q3 2026 results | The single most important print. (1) External third-party foundry revenue against $293m — the only line that can begin to identify the terminal margin; (2) consolidated operating margin against Q2's +11.1%; (3) the escrow derivative mark, which will move with the share price; (4) 2027 capex guidance after the CFO's "meaningfully increasing our investments" |
| Q3 2026 guidance already given | announced | Revenue $15.8–16.8bn, GAAP gross margin 41.0%, GAAP EPS $0.31, non-GAAP EPS $0.38 | Whether the sequential margin improvement holds; the guide implies +19.4% YoY, below the Q2 run-rate of +25.4% |
| ~21–28 Jan 2027 | ESTIMATE (2026-01-22, 2025-01-30, 2024-01-25) | Q4/FY2026 results and the FY2027 guide | The FY2026 Government Incentives note — the successor to the $529m operating benefit and the $1.0bn depreciation relief, now that post-August-2025 CHIPS money is equity-attributed rather than grant-accounted. Also the FY2026 cumulative capital-incentive reduction to gross PP&E (was $16.1bn) |
| ~late Apr 2027 | ESTIMATE (2026-04-23, 2025-04-24, 2024-04-25) | Q1 2027 results | Same tests; first full quarter under the raised capex |
| Undated, pending | filed, no date | Delaware derivative suit re the Warrant and Common Stock Agreement with the Department of Commerce | Motions to dismiss were filed May 2026. An adverse ruling would remove the $15.6bn derivative liability and the 241m warrants — and also the funding. Unquantifiable in either direction and deliberately not modelled |
| Continuous | ongoing | Escrowed-share releases as Secure Enclave cash is received | 7m released in Q2 2026, 13m in H1. 143m remain, of which 71m are contingent. Each release is dilution and each re-marks the derivative |
| 2027, undated | NOT ANNOUNCED | 14A node milestones | "14A" first appeared in the January 2026 release at 2.9 mentions per 10,000 words and has already faded to 1.8. No filing read for this memo attaches a date, a customer or a volume to 14A. No date is listed because none exists |